Optimal Hormone Replacement for Women With Premature Ovarian Insufficiency
Phase of Trial: Phase III
Latest Information Update: 19 Jul 2017
At a glance
- Drugs Estradiol (Primary) ; Estradiol (Primary) ; Ethinylestradiol (Primary) ; Medroxyprogesterone (Primary) ; Norgestimate (Primary) ; Progesterone (Primary)
- Indications Primary ovarian insufficiency
- Focus Therapeutic Use
- Acronyms HOPE
- 12 Jul 2017 Planned End Date changed from 1 Apr 2017 to 1 Apr 2018.
- 12 Jul 2017 Planned primary completion date changed from 1 Apr 2017 to 1 Apr 2018.
- 12 Oct 2016 New trial record